Dr. Budny attended medical school and completed his residency training in neurosurgery at University at Buffalo and obtained fellowship training in neurovascular surgery at the University of Western Ontario. Following his fellowship training in 1979, Dr. Budny joined the staff of University at Buffalo Neurosurgery. Since then, he has been an active and integral component of the department’s research, clinical and academic programs. Over the last 30 years, Dr. Budny has served as investigator for numerous groundbreaking trials to study the surgical treatment of cerebrovascular disease, including the bypass, CREST, CARESS, NASCET, COSS and VIVA studies. Clinically, his interests lie in all aspects of spinal surgery, carpal tunnel, ulnar neuropathy, peripheral neuropathy, vagal nerve stimulator, cerebrovascular, neuroendocrine and CT-guided stereotactic neurosurgery. Dr. Budny has traveled twice, as a private citizen, to Tuzla, Bosnia to train local neurosurgeons in carotid endarterectomies and transsphenoidal surgical procedures. Dr. Budny is certified by the American Board of Neurological Surgery, and is a member of the Congress of Neurological Surgeons (CNS) and the American Association of Neurological Surgeons (AANS). He also serves as chairman of the Millard Fillmore Gates Operating Room Committee and as president of the Kaleida Health Medical Staff. Dr. Budny holds the rank of colonel in the United States Army Reserve. In 2008, he volunteered four months of his time to providing expert neurosurgical treatment to the soldiers and civilian casualties at 332nd Theater Hospital at Camp Anaconda in Balad, Iraq. In October 2012, Dr. Budny embarked upon a four-month tour in Landstuhl, Germany with the U.S. Army Reserve Medical Corps. He is stationed at the Landstuhl Regional Medical and is responsible for providing neurosurgical treatment to soldiers who have been wounded during combat in Afghanistan.
Dr. Jason Davies is an Assistant Professor of Neurosurgery and Biomedical Informatics at the State University of New York (SUNY) at Buffalo, where he joined the department in 2016. He completed residency training in the Department of Neurological Surgery at University of California, San Francisco. He specializes in cerebrovascular and skull base neurosurgery, first under the mentorship of Dr. Michael Lawton for his open training, and subsequently having completed a fellowship in endovascular neurosurgery with UB Neurosurgery. He has extensive experience treating aneurysms, arteriovenous malformations, cavernous malformations, and arteriovenous fistulae, stroke, carotid stenosis, cerebral bypass, and other vascular disease using both open and endovascular approaches, and is able to offer comprehensive care for his patients. He also has experience in management of intracranial tumors and skull base and pituitary disease using the latest technological advances in endoscopy and minimally invasive methods. Dr. Davies graduated from Stanford University, where he obtained a BS in Chemistry with minors in Biological Sciences. He has a significant research background, starting with molecular and cell biology research in the lab of Dr. Richard Scheller studying the proteins involved in neuronal exocytosis. After graduation in 2001, he continued his work on exocytic proteins, shifting to a molecular and computational biophysics perspective in the lab of Dr. Bill Weis. Jason was accepted into the MD/PhD program at Stanford, where he continued his thesis work with Dr. Weis, culminating in several papers elucidated the atomic structural details of these proteins, as well as developing novel computational methods for studying dynamic protein structures at high resolution in real time. During the course of his residency, he spent a one-year post-doctoral fellowship with Dr. Adams Dudley developing computational methods in natural language processing and machine learning algorithms directed at finding ways to exploit the richness of data in electronic medical records. His active research interests focus on using bioinformatics tools to advance personalized medicine. He is working to develop of bioinformatics tools to improve the quantity and quality of data available for medical research, and to lower barriers to entry for all clinicians to contribute to medical knowledge. Furthermore, he is working to bring to bear more advanced machine learning and data analytic methods to better understand the insights contained within these rich data resources. These tools in combination will help us to better understand nuances of disease, as well as which patients are most apt to benefit from the various therapies we can offer. Dr. Davies is married with three energetic boys. He loves cycling and skiing with his family. He has co-founded and grown several early stage medical-related companies, including in the medical device and medical informatics realms. He has experience developing intellectual property, conducting early phase clinical device trials, and raising capital. He relishes working in technology-driven fields like endovascular neurosurgery and creating new solutions to address problems that impact human health. Medical School Stanford University School of Medicine Graduate School Stanford University School of Medicine, PhD Biophysics Residency in Neurological Surgery University of California, San Francisco, Department of Neurological Surgery Fellowship in Neuroendovascular Surgery University at Buffalo Neurosurgery, State University of New York at Buffalo
Neurological Surgery; Neurology
Dr. Fenstermaker graduated from the Northeastern Ohio Universities College of Medicine in 1981. He completed his neurosurgical residency at University Hospitals of Cleveleand and Case Western Reserve University School of Medicine in 1987. Thereafter, he was a NIH Post-Doctoral Research Fellow in Biochemistry and Pharmacology at Case Western Reserve University School of Medicine. Between 1989 and 1995, he was Assistant Professor of Neurological Surgery at Case Western Reserve University School of Medicine and Chief of Neurosurgery at the Cleveland Veterans Affairs Medical Center. Dr. Fenstermaker became certified by the American Board of Neurological Surgery in 1991. Currently, he is Chairman of the Department of Neurosurgery at Roswell Park Cancer Institute and Associate Professor and Director of Neurosurgical Oncology in the Department of Neurosurgery at the State University of New York at Buffalo. He co-directs the Brain Tumor Treatment Center and the new Gamma Knife Center both at Roswell Park. Dr. Fenstermaker's laboratory research program at Roswell Park Cancer Institute concentrates on the molecular oncogenesis of brain tumors. This involves studying the mechanisms by which certain growth factors and their receptors contribute to malignant glioma formation and progression and how these factors may be targeted to selectively kill tumor cells. Dr. Fenstermaker also performs clinical research into local therapies for brain tumors including the effects of intra-operative photodynamic therapy (PDT) on malignant gliomas.
Dr. Gibbons joined UBNS in July 1993 after graduating from the State University of New York at Buffalo neurosurgery residency training program. He underwent fellowship training in critical care and is board certified by the American Board of Neurological Surgery (ABNS). Dr. Gibbons directs the neurological critical care service and skull base clinical service and skull base laboratory at UBNS. He is a member of numerous professional societies, including the Society of Neurological Surgeons. He is a former President of the Medical Staff of Kaleida Health. He has served as president of the Faculty Council of the School of Medicine and Biomedical Sciences, University at Buffalo, New York. Additionally he is Director of Surgery and Operational Improvement at the Buffalo General Medical Center and The Gates Vascular Institute. Dr. Gibbons is considered an expert lecturer in neurosurgical education, surgical decision making and patient management for residents and surgeons at the national level. Areas of interest include the surgical treatment of brain, spinal and pituitary tumors, complex cervical spine disorders, and critical care
Neurological Surgery; Neuroradiology
Dr. L. Nelson Hopkins served as the chairman of the Department of Neurosurgery from 1989-2013 and recently earned the title of Distinguished Professor of neurosurgery and radiology from the State University of New York. After completing his undergraduate studies at Rutgers University, Dr. Hopkins earned a doctor of medicine degree cum laude from Albany Medical College. His post-graduate training included a surgical internship at Case Western Reserve, followed by neurology and neurosurgical training at UB. Ranking seventh among the most published neurosurgical departments in North America, he has established UB Neurosurgery as one of the most respected with patients traveling to Buffalo from around the world. Dr. Hopkins pioneered endovascular neurosurgery and has trained a new generation of neurosurgeon leaders skilled in catheter-based technology for minimally invasive neurosurgery. Active in national neurosurgery, Dr. Hopkins has served as a member of the board of directors of the American Association of Neurological Surgeons (AANS) and of the Executive Committee of the Stroke Council of the American Heart Association. He has served as Scientific and Annual Meeting Chairman for both the AANS and Congress of Neurological Surgeons. He is the former chairman of the Joint Section on Cerebrovascular Surgery and president of the American Academy of Neurological Surgery. Dr. Hopkins has been the principal investigator of several national clinical trials testing catheter-based technologies for the treatment of neurovascular diseases. He is a member of the editorial boards of NEUROSURGERY and World Neurosurgery and the author of more than 300 publications centered on the prevention and treatment of stroke. Dr. Hopkins has served on the faculty of numerous symposiums nationally and internationally and each year hosts multidisciplinary seminars along with industry leaders focused on assessing and managing complications associated with minimally invasive catheter-based interventions. Dr. Hopkins is an advocate of cross-specialty and multidisciplinary collaboration. He fostered the creation of the Toshiba Stroke & Vascular Research Center, bringing together physicists, chemists, aerospace engineers, neurosurgeons, cardiologists and radiologists to study the neurovascular circulation and develop innovative technologies and approaches for the diagnosis, treatment and prevention of neurovascular diseases. Dr. Hopkins conceived a new way to organize the multidisciplinary treatment of vascular disease and brought experts from around the world together to design the Gates Vascular Institute and then recruited the necessary partners to bring the Jacobs Institute and Gates Vascular Institute to life. He serves as chairman of the board of the GVI and President/CEO of the Jacobs Institute and its Center for Innovation in Medicine (CIM). A proponent of the global approach to revascularization for the improvement of outcomes for patients with vascular disease, Dr. Hopkins has served on the faculty of numerous symposiums nationally and internationally and each year hosts multidisciplinary seminars along with industry leaders focused on assessing and managing complications associated with minimally invasive catheter-based interventions.
Neurological Surgery; Neuroradiology
Dr. Elad Levy is Professor of Neurosurgery and Radiology, L. Nelson Hopkins, MD Chairman of the Department of Neurological Surgery, Jacobs School of Medicine at Biomedical Sciences, at State University of New York at Buffalo. In 2017 he was appointed as one of 12 National Directors to the American Board of Neurological Surgery. In 2018 he was appointed Secretary to the Congress of Neurological Surgeons (CNS) Executive Committee and appointed to the 2018 American Association of Neurological Surgeons (AANS) Ethics Committee for a two year term. His most recent award in 2018 was receiving the “2018 Drake Lectureship” at the CV Section at CNS. Dr. Levy has a national and global reputation in the field of neurovascular disease, and has co-authored over 300 peer-reviewed publications, including several in the New England Journal of Medicine. He has also co-authored many published books in neurovascular disease, his most recent being “Decision Making in Neurovascular Disease” Thieme Publishers, May 1, 2018. Dr. Levy is also the Co-Director, Gates Stroke Center and Cerebrovascular Surgery at Kaleida Health, Director of Endovascular Stroke Treatment and Research Medical Director of Neuroendovascular Services at Gates Vascular Institute (GVI). He has been a primary investigator in several clinical international research studies on carotid artery revascularization and stents, and served as the US Principle Investigator for the SWIFT PRIME trial published in the New England Journal of Medicine. Additionally, he has trained several physicians in using complex endovascular neurosurgical techniques, who now hold leadership positions in academic institutions in the United States and around the globe. Prior to his professorship at the University, Dr. Levy graduated from Dartmouth College and received his Doctor of Medicine degree with distinction from George Washington University. He completed a surgical internship and his neurosurgical residency at the University of Pittsburgh and his fellowship at the University at Buffalo. He also received his MBA from Northeastern University in 2013. Since becoming the Chairman at the University of Buffalo Neurosurgery, he has more than doubled the size of the faculty, one of the largest academic groups in New York State. In 2011, Dr. Levy spearheaded a local non-profit organization called PUCCS (Program for Understanding Childhood Concussion and Stroke). Dr. Levy, who serves as president and founder, has led the organization in raising nearly $500,000, which has been used to fund concussion research and education in the Western New York area.
Dr. Li, a graduate of Albany Medical College, received his residency training in neurosurgery at the University of Wisconsin Hospital and his fellowship training in pediatric neurosurgery at Children‘s Hospital of Pittsburgh. He has an interest in the study and management of brain tumors in the pediatric population, developmental spine malformations, the management of spasticity in children with cerebral palsy, and the surgical treatments of patients with seizures. Dr. Li has authored many papers and book chapters on pediatric neurosurgical topics. He is a member of the American Society of Pediatric Neurosurgeons, the Joint Section of Pediatric Neurosurgery, and the Children‘s Oncology Group.
Dr. Jeffrey Mullin is an Assistant Professor at the State University of New York at Buffalo who joined UBNS in August of 2018. His clinical focus centers around spinal deformity and biomechanics as well as treatment of disorders of the cervical, thoracic, and lumbar spine. His areas of expertise are herniated disc; spinal stenosis; scoliosis; spinal instability & deformity; spinal tumor and infection in both adult and pediatric patients. His research interests include spinal biomechanics, quality improvement/outcomes, and neurosurgical medical education. In addition to specialized spine surgery, Dr. Mullin also practices general cranial neurosurgery. Dr. Mullin comes to Buffalo after completing a fellowship in complex deformity spine at the University of Virginia. Prior to that he had completed his general neurosurgical residency at Cleveland Clinic. He received his medical degree from Georgetown University School of Medicine in 2010. He also received his MBA from the University of Notre Dame in 2006 and completed an enfolded fellowship in epilepsy surgery at Cleveland Clinic from 2014-2016. Dr. Mullin has authored several peer-reviewed publications and book chapters and has presented at numerous national neurosurgical meetings. He is an active member of AANS, CNS, and CSNS. Dr. Mullin sees patients at both the Amherst and Orchard Park UB Neurosurgery offices and performs surgeries at Buffalo General Medical Center/Gates Vascular Institute.
Neurological Surgery; Neurology
I have two major research interests: trophic factors as novel treatments for Parkinson‘s disease and CNS neoplasms. My lab has been characterizing the response to trauma in the caudate nucleus of parkinsonian animals. This work grew out of the observation that tissue grafts for parkinsonism lead to modest behavioral improvement, even when the graft did not survive. We have shown that several trophic factors are present in the caudate of rats after trauma which simulates graft placement. Both brain derived neurotrophic factor and ciliary neurotrophic factor are found in the caudate predictably at intervals after the surgical trauma. Further, there is at least one other, as yet unidentified factor present after trauma in the caudate. We have moved beyond identification to use of BDNF in parkinsonian models. Infusion of BDNF into the dopamine deficient caudate of a hemiparkinsonian rat leads to behavioral improvement and increased tyrosine hydroxylase (TH) staining, the rate limiting enzyme for dopamine synthesis. We are currently working on a delivery system to distribute BDNF, or other macromolecules like trophic factors, in the striatum of primates. The second area of active interest is in two forms of CNS neoplasia: leukemic meningitis and glioblastoma multiforme (GBM). We have created an animal model of leukemic meningitis in the athynic (nude) rat, using a human leukemic cell line. In collaboration with Dr. Steve Greenberg, we are working on a gene therapy approach using a white cell specific promoter and the viral thymidine kinase "suicide" enzyme. We are testing the constructs in vitro and in the nude rat model. In addition, we are working withDr. Greenberg to study the biology of GBM by transfecting human GBM cell lines with genes for vascular growth factors. Basic fibroblast growth factor, transforming growth factor beta, and endothelin-1 are currently being studied. The behavior of the transfected GBM cell lines are characterized in vitro, and after implantation into the frontal lobe of nude rats. By understanding how the transfected genes affect tumor growth, we hope to devise novel treatment strategies, potentially utilizing gene therapy.
Dr. Pollina is an Assistant Professor of Neurosurgery at the State University of New York (SUNY) at Buffalo who joined UBNS in 2013. Dr. Pollina, who is a board certified neurosurgeon, is the Director of Spine Surgery. After receiving his BA in Economics from Fairfield University in 1990, Dr. Pollina completed medical school at SUNY Buffalo, School of Medicine and Biomedical Sciences in 1994. He completed his neurosurgical residency at SUNY Buffalo as well. Dr. Pollina has a focus in the treatment of disorders of the cervical, thoracic, and lumbar spine. His areas of expertise are low back and neck pain; herniated disc; spinal stenosis; scoliosis; spinal instability; spinal tumor and infection; carpal/cubital tunnel syndrome; and intracranial pathology. His research interests include motion sparing/preserving technology of the spine; minimal access approaches and techniques to the spine; osteo-biologics of spinal fusion; and spine surgery outcome-based research.
Gene Expression; Gene therapy; Molecular Basis of Disease; Molecular and Cellular Biology; Neurobiology; Neuropharmacology; Transcription and Translation
The efforts in my lab are broadly directed at the translational research of neuroprotective/neurorestorative agents. Specifically, I am focused on the preclinical and clinical development of therapies used to prevent behavioral and cognitive deficits following traumatic brain injury (TBI) and stroke. Over 800,000 patients each year in the US suffer stroke and more than twice that number suffer TBI. Unfortunately there are currently no FDA approved therapies for TBI. TPA is the only therapy approved for stroke but is only applied in about 4% of stroke patients. Furthermore, while TPA is thrombolytic, it does not limit the cascade of pathology initiated by the original occlusion. We have demonstrated that low dose methamphetamine is highly neuroprotective when administered as an acute treatment (within 12 hours after injury) following severe stroke or TBI. We have show that treatment with methamphetamine significantly improve cognition and functional behavior in rat models of these injuries. This effect is primarily mediated through the activation of a dopamine/PI3K/AKT signaling cascade and results in the preservation of primary neurons, and axons, as well as enhanced granule cell neurogenesis and white mater track remodeling. Furthermore, gene expression analysis suggests methamphetamine treatment significantly reduces pro-inflammatory signals and stabilizes the blood brain barrier. These observations led us to further investigate the potential of low dose methamphetamine to reduce or prevent post-traumatic epilepsy. Using long-term video/EEG monitoring, we determined that methamphetamine treatment significantly reduces the incidence and susceptibility to post traumatic epilepsy/seizures after severe TBI in rats. This becomes quite relevant when one considers that many patients with post-traumatic epilepsy are pharmacoresistant. We are continuing to use the TBI model to investigate the causes of post-traumatic epilepsy and test novel therapeutics. In addition to single severe injury, we are also very interested in the effects of repeated mild TBIs. It has now been observed that multiple mild TBIs can cause clinical seizures in about 50% of rats. Therefore, we are also using this model to investigate the causes of post-traumatic epilepsy and potential therapeutic interventions. We have now completed a phase I human trial of methamphetamine in healthy volunteers and are moving to conduct a phase IIa dose escalation safety study in TBI patients. In addition, we are currently using NGS to examine plasma miRNA changes as potential biomarkers and objective measures of activity to support the phase IIa study. In addition to small molecules, my lab also is investigating the development of Adeno- associated virus (AAV) vector based gene therapy approaches to the treatment of CNS injuries such as post-traumatic epilepsy. Specifically, we are using recombinant AAV vectors to modulate targeted gene expression in a temporal, tissue-specific and cell type-specific manner within the CNS.
Dr. Renée Reynolds is an Assistant Professor of Neurosurgery at State University of New York at Buffalo. She completed her neurosurgical training at the Duke University Medical Center and received her medical degree from SUNY Upstate Medical University. She also completed a one-year fellowship at Seattle Children‘s Hospital/University of Washington in pediatric neurosurgery. Dr. Reynolds’ areas of expertise are: pediatric neurosurgery, including congenital neurosurgical conditions; brain tumors; surgical management of epilepsy; craniofacial disorders; hydrocephalus; and spasticity. Her research interests are in the areas of immunotherapy for pediatric brain tumors and management of hydrocephalus. She has several publications in peer-reviewed journals and has presented at national meetings. She is a member of the Congress of Neurosurgeons and the Children‘s Oncology Group.
Dr. Riley is an Assistant Professor of Neurosurgery at the State University of New York (SUNY) at Buffalo, having joined in Fall 2017. Dr. Riley is the Medical Director of Functional Neurosurgery and Fellowship Director for the Stereotactic & Functional Neurosurgery fellowship position. After receiving a Bachelors of Science in Engineering from Mercer University in 2000, Dr. Riley completed medical school at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University (2009), simultaneously obtaining a Masters of Science in Pathology. He went on to complete his neurosurgical residency at Emory University (2016). During his neurosurgical residency, he completed an enfolded Stereotactic and Functional Neurosurgery Fellowship and completed a post-residency Fellowship position in the same at Thomas Jefferson University Hospital. Dr. Riley placed emphasis on this subspecialized training to be best positioned to provide a full range of surgical treatment options to patients with afflictions affecting the function of the central nervous system. These include surgical treatments for the broad spectrum of Movement Disorders, epilepsies, pain syndromes, and emerging psychiatric indications. Throughout medical school and residency, Dr. Riley has meaningfully and longitudinally participated in translational and clinical research agendas. These have included both small and large animal work and have focused on the clinical translation of biologics-based therapeutics with an emphasis on development of approaches to therapeutics delivery to the central nervous system. This has provided a background in all aspects of translation from large animal work through clinical trial completion. Active research interests include the use of small animal epilepsy models to develop and optimize neuromodulation-based candidate therapies for the treatment of medically refractory epilepsy. Dr. Riley’s additional professional interests include international neurosurgical outreach and program development. .
Neurological Surgery; Neuroradiology
Dr. Adnan Siddiqui, MD, PhD, is a Professor of Neurosurgery and Radiology who joined UBNS in January 2007. He completed fellowship training in Interventional Neuroradiology, Cerebrovascular Surgery and Neurocritical Care from Thomas Jefferson University in Philadelphia. He completed his Neurosurgical residency at Upstate Medical University and received his PhD in Neuroscience from the University of Rochester and medical degree from Aga Khan University, Pakistan. Though Dr. Siddiqui is well trained in all general neurosurgical procedures, including brain tumor, spine and peripheral nerve surgery, because of specialized training, he has gravitated toward vascular diseases involving the brain and spinal cord. Dr. Siddiqui has special interest and expertise in the performance of complementary microsurgical, radiosurgical and endovascular techniques for the comprehensive management of cerebrovascular conditions. This spectrum of disease includes aneurysms and arteriovenous malformations, as well as dural, cavernous and spinal fistulae. He has special interests in acute stroke management with intra-arterial thrombolysis, as well as endovascular and microsurgical management of extracranial and intracranial vascular occlusive disease. Other clinical interests include endovascular management of intractable epistaxis; preoperative head, neck, and brain tumor embolization; resection of skull base tumors; endoscopic surgery for aneurysms and pituitary tumors; third ventriculostomy; and arachnoid cysts. The Neuroendovascular Research and Stroke Service is led by Dr. Siddiqui, who is proud to lead UB‘s Department of Neurosurgery, which was ranked 7th in academic impact in North America by the Journal of Neurosurgery. He serves as a reviewer for Stroke, Neurosurgery, Journal of Neurosurgery and Journal of Neurointerventional Surgery as well as many others. He has over 100 peer reviewed publications, more than 50 chapters and has been invited to more than 200 national and international lectureships. Dr. Siddiqui is currently a member of the Executive Council of the Joint Section of Cerebrovascular Surgery of the American Association of Neurological Surgery (AANS) and is Chairman of the Nominating Committee. He has served on Endovascular Task Force of AANS and been on multiple scientific committees on AANS, Society of Neurointerventional Surgery and the Congress of Neurological Surgeons. Dr. Siddiqui is married and has three children. He is a proud Buffalonian who is challenged and invigorated by taking care of neurosurgical patients and their families. He is grateful for the opportunity to work at the Gates Vascular Institute, a facility with some of the world‘s best technologies, where he and other experts can interact with leading researchers in order to make scientific advancements at the Toshiba Stroke & Vascular Research Center.
Dr. Snyder joined UBNS in 2011 after completing his fellowship training in endovascular neurosurgery with UB Neurosurgery and spent 6 months as a research fellow at the Barrow Neurological Institute under Dr. Robert Spetzler. He completed his neurosurgical residency at UB and received his PhD in biophysics under the guidance of Dr. Frederick Sachs specializing in mechanoelectric transduction of cellular membranes. He is trained in all general neurosurgical procedures, including brain tumor, spine, and peripheral nerve surgery. Dr. Snyder‘s extra training in open cerebrovascular techniques and well as his endovascular fellowship give him the necessary tool set for specialization in the comprehensive management of neurovascular pathology in both the brain and spinal cord, including treatment of aneurysms, arteriovenous malformations, arteriovenous fistulas, and stroke. He has special interests and expertise in physiological imaging of the brain and its use in the evaluation and management of acute stroke patients, as well as all endovascular techniques for acute stroke intervention for both extracranial and intracranial vascular occlusive disease. Dr. Snyder has been awarded a Congress of Neurological Surgeons Vascular Fellowship for Cerebrovascular Research, a Toshiba Stroke Imaging Research Fellowship, the Gold Humanism in Excellence in Teaching, and been named the UB Neurosurgery Resident of the Year. Active research interests include use of CT Perfusion (CTP) for acute stroke management, application of perfusion imaging to on table angiography, glasses free 3D imaging in both the operating room and endovascular suite, as well as basic science research on the role of mechanosensitive ion channels in both in aneurysm formation and vasospasm. He has published numerous articles and holds multiple patents. He is an active member of several national neurosurgical and interventional organizations and has given multiple CME lectures nationwide on the role of CTP in endovascular stroke management.